Sven Borho
Director/Board Member at WORLDWIDE HEALTHCARE TRUST PLC
Net worth: 258 068 $ as of 2024-04-29
Network origin in Sven Borho first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
73
| Subsidiary | Investment Managers | 73 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds.
53
| Private Company | Investment Managers | 53 |
| Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 12 | |
| Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 8 | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY.
4
| Subsidiary | Financial Conglomerates | 4 |
K Bygg Östergyllen AB (Sweden)
 K Bygg Östergyllen AB (Sweden) Real Estate DevelopmentFinance Part of Kesko Oyj, K Bygg Östergyllen AB is a building trade services company based in Linköping, Sweden. K Bygg Östergyllen AB provides building trade services. The CEO of the Swedish company is Sven Heinz Borho.
3
| Subsidiary | Real Estate Development | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sven Borho via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MORGAN STANLEY | Investment Banks/Brokers | Corporate Officer/Principal Private Equity Analyst | |
| GELESIS INC | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
| Queen's University | College/University | Undergraduate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Graduate Degree Doctorate Degree | |
| New York University | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Undergraduate Degree | |
Science Museum Group
 Science Museum Group Other Consumer ServicesConsumer Services Science Museum Group operates science and industry museums. It maintains and exhibits historical science and technology items such as steam engines, old film projectors, and animal classification systems. The company was founded in 1857 and is headquartered in London, the United Kingdom. | Other Consumer Services | Chairman Director/Board Member | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| FORTRESS INVESTMENT GROUP LLC | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer | |
| SCISPARC LTD. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Genome Research Ltd.
 Genome Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of The Wellcome Trust Ltd., Genome Research Ltd. is a world-leading genomics research institute founded in 1992. The company is based in Cambridge, UK. Genome Research delivers therapeutic, diagnostic, and production benefits in areas such as cancer, immunology, public health, and personalized treatment. The British company tackle some of the most difficult challenges in genomic research, demanding science at scale and a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. The company's work helps improve human health and understand life on a molecular level. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| XTANT MEDICAL HOLDINGS, INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| ENTERO HEALTHCARE SOLUTIONS LIMITED | Medical Distributors | Director/Board Member Director/Board Member | |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation. | Packaged Software | Director/Board Member Director/Board Member | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 34 |
| United Kingdom | 9 |
| Israel | 5 |
| Canada | 3 |
| Ireland | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 16 |
| Finance | 5 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 451 |
| Independent Dir/Board Member | 143 |
| Corporate Officer/Principal | 119 |
| Chairman | 99 |
| Private Equity Investor | 86 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jonathan Silverstein | 42 |
| Peter Thompson | 39 |
| Iain Dukes | 30 |
| Erez Chimovits | 30 |
| David Willetts | 29 |
| Rishi Gupta | 29 |
| Sunny Sharma | 29 |
| Sarah Bates | 28 |
| David Bonita | 27 |
| Guo-Liang Yu | 27 |
| Steve Bates | 25 |
| Peter Stephen Keen | 25 |
| David Holbrook | 23 |
| Dina Chaya | 23 |
- Stock Market
- Insiders
- Sven Borho
- Company connections
